Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study)

Detalles Bibliográficos
Autores principales: Martin-Blondel, Guillaume, Marcelin, Anne-Genevieve, Soulié, Cathia, Kaisaridi, Sofia, Lusivika-Nzinga, Clovis, Dorival, Céline, Nailler, Laura, Boston, Anaïs, Melenotte, Cléa, Gaube, Géraldine, Choquet, Christophe, Liblau, Roland, Carrat, Fabrice, Yordanov, Youri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of The British Infection Association. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988484/
https://www.ncbi.nlm.nih.gov/pubmed/35398409
http://dx.doi.org/10.1016/j.jinf.2022.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988484/
https://www.ncbi.nlm.nih.gov/pubmed/35398409
http://dx.doi.org/10.1016/j.jinf.2022.04.010

Ejemplares similares